🇺🇸 FDA
Preview mode — showing bulk-ingested data not yet promoted to production. Hide preview

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
3,385
Companies
1,062
Pipeline programs
18,156

Quick answer

NovaPharmaNews tracks 3,385 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

122 results for “VIR” Clear

  1. famciclovir

    FAMVIR Teva Pharma GmbH

    ORAL approved

  2. fomivirsen

    VITRAVENE

    S01AD08

  3. fomivirsen sodium

    VITRAVENE PRESERVATIVE FREE

    INJECTION approved

  4. fosamprenavir

    TELZIR

    J05AE07

  5. fosamprenavir calcium

    FOSAMPRENAVIR CALCIUM

    ORAL approved

  6. fostemsavir

    RUKOBIA

    J05AX

  7. fostemsavir tromethamine

    RUKOBIA

    ORAL approved

  8. ganciclovir

    VITRASERT IMPLANT

    OPHTHALMIC approved

    J05AB06

  9. ganciclovir sodium

    GANCICLOVIR SODIUM Regeneron Ireland Designated Activity Company (DAC)

    INJECTION approved

  10. glecaprevir

    MAVIRET

    ORAL approved

    J05AP57

  11. human papillomavirus 9-valent vaccine (recombinant, adsorbed)

    GARDASIL 9

    J07BM03

  12. human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed)

    CERVARIX

    J07BM02

  13. human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed)

    GARDASIL

    J07BM01

  14. indinavir

    CRIXIVAN

    J05AE02

  15. indinavir sulfate

    CRIXIVAN

    ORAL approved

  16. influenza vaccine (h1n1)v (split virion, inactivated, adjuvanted)

    PANDEMRIX

    J07BB02

  17. influenza vaccine (h1n1)v (whole virion, vero cell derived, inactivated)

    CELVAPAN

    J07BB01

  18. influenza vaccine (split virion, inactivated)

    INTANZA

    J07BB02

  19. lamivudine, nevirapine, and stavudine

    LAMIVUDINE, NEVIRAPINE, AND STAVUDINE

    ORAL approved

  20. ledipasvir

    HARVONI

    ORAL approved

  21. ledispavir

    HARVONI

    J05AX65

  22. lenacapavir

    SUNLENCA

    SUBCUTANEOUS approved

    J05AX31

  23. lenacapavir sodium

    SUNLENCA

    SUBCUTANEOUS approved

  24. letermovir

    PREVYMIS

    ORAL approved

    J05

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 3,385 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources